Eribulin Mesylate in Combination With Intermittent Erlotinib in Patients With Previously Treated, Advanced Non-Small Cell Lung Cancer
Clinical trial NCT01104155 · COMPLETED
Trial details
- NCT number
- NCT01104155
- Sponsor
- Eisai Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-02-22
- Primary completion
- 2011-04-07
- Enrollment
- 123
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.